M

Member

Speaking in the House of Lords on 9 November 2026

Debate

Health Bill

Contribution

Earlier this year the Government accepted the national screening committee’s recommendation for England’s first targeted programme for men aged between 45 and 61 with a BRCA2 variant and a family history of cancer. This is wonderful news and I welcomed it. I also warmly welcome the fantastic further investment in the second stage of the TRANSFORM trial, which will now be available to all eligible Black men. These are real steps forward, because one in four Black men might well get prostate cancer—but the programme will reach only a few thousand men each year.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.